Our news

On the last 11th of February 2021, took place the third meeting of the nAngioDerm Project, held online due to COVID-19 pandemic restrictions. The meeting counted with the participation of all the partners and was the opportunity to discuss their results and set up the next steps of the project.

Abstract: Tissue engineering and regenerative medicine approaches use biomaterials in combination with cells to regenerate lost functions of tissues and organs to prevent organ transplantation. However, most of the current strategies fail in mimicking the tissue’s extracellular matrix properties. In order to mimic native tissue conditions, we developed cell-derived matrix (CDM) microtissues (MT).

Applications are invited from suitably qualified candidates for a three-years, fully funded, full-time PhD position at the University of Ioannina, Greece. The position is available from February 2021 onwards. The project aims to develop multifunctional collagen-based implantable devices for wound healing purposes. The produced scaffolds will be characterised using an array of biochemical, biophysical, biomechanical and biological methods. The release profile / pharmacokinetics of various therapeutic / bioactive molecules will be assessed. Extensive in vitro analysis will be conducted using human permanently differentiated and stem cell populations. Preclinical analysis of the produced scaffolds will also be conducted. Closing date for receipt of applications is 24:00 on Friday, 8^th of January 2021.

Applications are invited from suitably qualified candidates for a three-years, fully funded, full-time PhD position at the University of Ioannina, Greece. The position is available from February 2021 onwards. The project aims to develop tissue engineered drug screening and implantable devices for wound healing purposes. The produced devices will be characterised using an array of biophysical, biomechanical, biochemical and biological methods. In vitro analysis will be conducted using human permanently differentiated and stem cell populations. Preclinical analysis of the produced devices will also be conducted. Closing date for receipt of applications is 24:00 on Friday, 8^th of January 2021.